Agonist-dependent differential effects of berberine in human platelet aggregation

Phytotherapy Research

Volumn 12, Issue SUPPL. 1, 1998, Pages

  Shah, Bukhtiar H ^a   Nawaz, Z ^a   Saeed, S A ^a   Gilani, A H ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

Berberine; Collagen; Human platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; BERBERINE; CALCIMYCIN; CALCIUM IONOPHORE; COLLAGEN; CYCLIC AMP; PROTEIN G; THROMBOXANE A2;

CALCIUM TRANSPORT; CELL ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HUMAN; HUMAN CELL; MEDICINAL PLANT; NORMAL HUMAN; PHYTOTHERAPY; THROMBOCYTE AGGREGATION;

EID: 0031700941     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(1998)12:1+3.0.CO;2-J     Document Type: Conference Paper

References (23)

1. Akhter, M. H., Sabir, M., and Bhide, N. K. (1977). Antiinflammatory effect of berberine in rats injected locally with cholera toxin. Indian J. Med. Res. 65, 131-141.
2. Akhter, M. H., Sabir, M., and Bhide, N. K. (1979). Possible mechanism of antidiarrheal effect of berberine. Indian J. Med. Res. 70, 233-241.
3. Amin, A. H., Subbaiah, T. V., and Abbasai, K. M. (1969). Berberine sulphate: antimicrobial activity, bioassay and mode of action. Can. J. Microbiol. 15, 1067-1076.
4. Bhide, M. B., Chawan, S. R., and Dutta, N. K. (1969). Absorption, distribution and excretion of berberine. Indian J. Med. Res. 57, 2128-2131.
5. Bova, S., Padrini, R., Goldman, W. F., Berman, D. M., and Cargnelli, G. (1992). On the mechanism of vasodilating action of berberine: possible role of inositol lipid signalling system. J. Pharmac. Exp. Ther. 261(1), 318-323.
6. Brass, L. F., Hoscie, J. A., and Manning, D. R. (1993). Signalling through G proteins and G protein-coupled receptors during platelet activation. Thromb. Haemost. 70, 217-223.
7. Chiou, W. F., Yen, M. H., and Chen, C. F. (1991). Mechanism of vasodilatory efect of berberine in rat mesenteric artery. Eur. J. Pharmacol. 204(1), 35-40.
8. Gilani, A. H., and Janbaz, K. H. (1994). Studies on hepatoprotective effect of berberine. Can. J. Physiol. Pharmacol. 72, Suppl-1, p.22.1.36.
9. Heemskerk, J. W. M., and Sage, O. (1994). Calcium signalling in platelets. Platelets 5, 295-316.
10. Hourani, S. M. O., and Hall, D. A. (1994). Receptors for ADP on human platelets. Trends Pharmacol. Sci. 15, 103-108.
11. 2-adrenoceptors. Life Sci. 49, 315-324.
12. Lesnau, A., Hils, J., Pohl, G., Beyer, G., Janka, M., and Hoa, L. T. (1990). Antiviral activity of berberine salts. Pharmazie 45, 638-639.
13. Mekawi, M. (1966). Effect of berberine on Vibrio cholera and its endotoxin. J. Egypt Med. Assoc. 49, 554-559.
14. Polanowska-Grabowska, R., and Gear, A. R. L. (1994). Role of cyclic nucleotides in rapid platelet adhesion to collagen. Blood 83(9), 2508-2515.
15. Shah, B. H., and Saeed, S. A. (1995). Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine. Res. Comm. Mol. Path. Pharmacol. 89(2), 157-164.
16. Shah, B. H., Shamim, G., Khan, S., and Saeed, S. A. (1996). Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets. Biochem. Mol. Biol. Int. 38, 1135-1141.
17. Shah, B. H., Virani, S. S., Safdar, B., Nawaz, Z., Saeed, S. A., and Gilani, A. H. (1997). The antiplatelet aggregatory activity of Acacia nilotica is due to blockade of calcium influx through membrane calcium channels. Gen. Pharmacol. 29, 251-255.
18. Marin, N. J. A., Maciel, B. C., Seeches, A. L., and Gallo, J. A. (1988). Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin. Cardiol. 11, 253-260.
19. Smaz, Z., Desperak, N. A., and Obojska, K. (1965). Pharmacological investigation of the stimulation of bile secretion and bile flow by berberine sulfate. Dissertations Pharm. 17, 429-436.
20. Tsai, C. S., and Ochillo, R. F. (1991). Pharmacological efects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch. Int. Pharmacodyn. Thera. 310(1/2), 116-131.
21. Wu, J. F., and Liu, T. P. (1995). Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats treated with reversible middle cerebral artery occlusion. Yao-Hsueh-Hsueh-Pao 30, 98-102.
22. Yasukawa, K., Takido, M., Ikekawa, T., Shimada, F., Takeuchi, M., and Nakagawa, S. (1991). Relative inhibitory activity of berberine-type alkaloids against 12-O-Tetradecanolphorbol-13-acetate-induced inflammation in mice. Chem. Pharm. Bull. 39, 1462-1465.
23. Zhu, B., and Ahrens, F. (1983). Antisecretory effects of berberine with morphine, clonidine, L-phenylephrine, yohimbine or neostigmine. Eur. J. Pharmacol. 96, 11-19.